2005
DOI: 10.1007/s11095-005-5421-2
|View full text |Cite
|
Sign up to set email alerts
|

pH-Sensitive Polymer Blends Used as Coating Materials to Control Drug Release from Spherical Beads: Elucidation of the Underlying Mass Transport Mechanisms

Abstract: The obtained new knowledge can be used to effectively adjust desired drug release mechanisms and, thus, release patterns.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(20 citation statements)
references
References 24 publications
0
19
0
1
Order By: Relevance
“…This is underlined by the change in pellet diameter and by the lack of change in roundness. The constant flow of water into the pellet would initially increase its size up to a limit when the crack appears (33). At this point, the inner liquid would flow out of the pellet and its diameter would decrease suddenly.…”
Section: Dissolution Studies Of Coated Pelletsmentioning
confidence: 99%
“…This is underlined by the change in pellet diameter and by the lack of change in roundness. The constant flow of water into the pellet would initially increase its size up to a limit when the crack appears (33). At this point, the inner liquid would flow out of the pellet and its diameter would decrease suddenly.…”
Section: Dissolution Studies Of Coated Pelletsmentioning
confidence: 99%
“…[136][137][138][139] To optimize the benefits, the design of a controlled release system requires simultaneous considerations of several factors, 140 such as the chemical-physical properties of the drug, the route of administration, 141 the nature of the delivery vehicle, the mechanism of drug release, the potential for targeting, and biocompatibility. Because of the extensive interdependency of those factors, it is not easy to establish a sequential process for designing a controlled drug delivery system, 142 which can bring both therapeutic and commercial value to health care products. 143 Many drug delivery technology companies enjoy a good return on their investments in the form of increased revenues and market share, and it is a very fast-growing segment of the economy.…”
mentioning
confidence: 99%
“…Since the ratio of carboxyl to ester groups in the polymer chains of Eudragit® S100 is 1:2 and 1:1 in Eudragit® L100, the lower ratio of carboxyl groups in S100 causes a lesser degree of ionization in an alkaline environment and therefore a decreased rate of solubilization [46]. By varying the type of Eudragit® polymer blend and ratio, the resulting drug release and dissolution kinetics in response to changing pH can be varied accordingly [47]. A ratio of 4:1 of Eudragit® L100 to Eudragit® S100 [48,49] was used in this study (Table 1) for the purpose of allowing the increased presence of Eudragit® L100 to cause pore formation, creating channels for alkaline media to penetrate the coating, causing dissolution of the polymer coat, and releasing the capsule contents.…”
Section: Discussionmentioning
confidence: 99%